Cargando...
Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation
Fingolimod is an oral sphingosine‐1‐phospate (S1P) receptor modulator for the treatment of relapsing‐remitting multiple sclerosis (RRMS). In addition to therapeutic effects on lymphoid and neural tissue, fingolimod influences cardiovascular system by specific S1P‐receptor modulation. The effects of...
Gardado en:
| Publicado en: | Physiol Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5027338/ https://ncbi.nlm.nih.gov/pubmed/27624686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.12870 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|